Technical Articles

CD30/TNFRSF8作为淋巴瘤免疫治疗靶点的潜力与研究工具
The potential of CD30/TNFRSF8 as a target for lymphoma immunotherapy and research tools
发布时间 2026-02-03
In the complex landscape of lymph system malignancies, identifying highly specific tumor-associated antigens is crucial for developing effective immunotherapies.
View details
  • Cancer
  • Alexa Fluor 647-Labeled CD30/TNFRSF8 His Tag protein
  • Malignant tumor
  • Lymphoma
Total 1
  • 1
Go to